The decision to continue, reduce, or stop semaglutide should be made with your healthcare provider based on symptom severity, the benefit you are receiving from the medication, and alternative management options
Inadequate Lifestyle Modifications Wegovy is licensed as an adjunct to a reduced-calorie diet and increased physical activitynot as monotherapy
The general adult weight-management indication includes patients with an initial: BMI of 30 kg/m2 or above, or BMI from 27 kg/m2 to below 30 kg/m2 with at least one weight-related health condition Relevant conditions may include: high blood pressure abnormal cholesterol levels obstructive sleep apnoea cardiovascular disease prediabetes type 2 diabetes Meeting these general criteria does not guarantee that treatment will be prescribed
These may include gastrointestinal issues like nausea, vomiting, and diarrhea, as well as other serious conditions such as pancreatitis
And tourist activities often involve more walking and sun exposure than your typical daily routine
